Line | Label | W | B | D-P | Value | Source | Message |
1 | Dimensions period from 2001-01-01 to 2001-12-31 for SAMP Scenario-1 |
2 | U-Monetary |
3 | company:By Product (Placeholder)//company:All Products |
4 | company:Sales[..., company:By Region (Placeholder)//company:All Regions] | | | INF | 32,465,000 | both | OK |
5 | company:Sales[..., company:By Region (Placeholder)//company:US and Canada Region] | 1 | | INF | 10,137,000 | inst | |
6 | company:Sales[..., company:By Region (Placeholder)//company:Europe Region] | 1 | | INF | 10,396,000 | inst | |
7 | company:Sales[..., company:By Region (Placeholder)//company:Asia Region] | 1 | | INF | 3,210,000 | inst | |
8 | company:Sales[..., company:By Region (Placeholder)//company:Other Regions] | 1 | | INF | 8,722,000 | inst | |
|
9 | company:By Region (Placeholder)//company:All Regions |
10 | company:Sales[..., company:By Product (Placeholder)//company:All Products] | | | INF | 32,465,000 | both | OK |
11 | company:Sales[..., company:By Product (Placeholder)//company:Pharmaceuticals Segment] | 1 | | INF | 15,275,000 | inst | |
12 | company:Sales[..., company:By Product (Placeholder)//company:Consumer Health Segment] | 1 | | INF | 5,752,000 | inst | |
13 | company:Sales[..., company:By Product (Placeholder)//company:Generics Segment] | 1 | | INF | 1,823,000 | inst | |
14 | company:Sales[..., company:By Product (Placeholder)//company:Other Segments] | 1 | | INF | 9,615,000 | inst | |
|
15 | Dimensions period from 2002-01-01 to 2002-12-31 for SAMP Scenario-1 |
16 | U-Monetary |
17 | company:By Product (Placeholder)//company:All Products |
18 | company:Sales[..., company:By Region (Placeholder)//company:All Regions] | | | INF | 35,805,000 | both | OK |
19 | company:Sales[..., company:By Region (Placeholder)//company:US and Canada Region] | 1 | | INF | 12,649,000 | inst | |
20 | company:Sales[..., company:By Region (Placeholder)//company:Europe Region] | 1 | | INF | 10,374,000 | inst | |
21 | company:Sales[..., company:By Region (Placeholder)//company:Asia Region] | 1 | | INF | 4,371,000 | inst | |
22 | company:Sales[..., company:By Region (Placeholder)//company:Other Regions] | 1 | | INF | 8,411,000 | inst | |
|
23 | company:By Region (Placeholder)//company:All Regions |
24 | company:Sales[..., company:By Product (Placeholder)//company:All Products] | | | INF | 35,805,000 | both | OK |
25 | company:Sales[..., company:By Product (Placeholder)//company:Pharmaceuticals Segment] | 1 | | INF | 18,150,000 | inst | |
26 | company:Sales[..., company:By Product (Placeholder)//company:Consumer Health Segment] | 1 | | INF | 6,514,000 | inst | |
27 | company:Sales[..., company:By Product (Placeholder)//company:Generics Segment] | 1 | | INF | 1,973,000 | inst | |
28 | company:Sales[..., company:By Product (Placeholder)//company:Other Segments] | 1 | | INF | 9,168,000 | inst | |
|
29 | Dimensions period from 2003-01-01 to 2003-12-31 for SAMP Scenario-1 |
30 | U-Monetary |
31 | company:By Product (Placeholder)//company:All Products |
32 | company:Sales[..., company:By Region (Placeholder)//company:All Regions] | | | INF | 32,038,000 | both | OK |
33 | company:Sales[..., company:By Region (Placeholder)//company:US and Canada Region] | 1 | | INF | 10,214,000 | inst | |
34 | company:Sales[..., company:By Region (Placeholder)//company:Europe Region] | 1 | | INF | 11,901,000 | inst | |
35 | company:Sales[..., company:By Region (Placeholder)//company:Asia Region] | 1 | | INF | 5,639,000 | inst | |
36 | company:Sales[..., company:By Region (Placeholder)//company:Other Regions] | 1 | | INF | 4,284,000 | inst | |
|
37 | company:By Region (Placeholder)//company:All Regions |
38 | company:Sales[..., company:By Product (Placeholder)//company:All Products] | | | INF | 32,038,000 | both | OK |
39 | company:Sales[..., company:By Product (Placeholder)//company:Pharmaceuticals Segment] | 1 | | INF | 20,181,000 | inst | |
40 | company:Sales[..., company:By Product (Placeholder)//company:Consumer Health Segment] | 1 | | INF | 6,675,000 | inst | |
41 | company:Sales[..., company:By Product (Placeholder)//company:Generics Segment] | 1 | | INF | 2,433,000 | inst | |
42 | company:Sales[..., company:By Product (Placeholder)//company:Other Segments] | 1 | | INF | 2,749,000 | inst | |
Contexts |
---|
ID | D-2003-All |
Entity ID | SAMP |
Scheme | http://www.SampleCompany.com |
Period | from 2003-01-01 to 2003-12-31 |
Scenario | company:By Region (Placeholder)//company:All Regions |
Scenario | company:By Product (Placeholder)//company:All Products |
|
ID | D-2002-All |
Entity ID | SAMP |
Scheme | http://www.SampleCompany.com |
Period | from 2002-01-01 to 2002-12-31 |
Scenario | company:By Region (Placeholder)//company:All Regions |
Scenario | company:By Product (Placeholder)//company:All Products |
|
ID | D-2001-All |
Entity ID | SAMP |
Scheme | http://www.SampleCompany.com |
Period | from 2001-01-01 to 2001-12-31 |
Scenario | company:By Region (Placeholder)//company:All Regions |
Scenario | company:By Product (Placeholder)//company:All Products |
|
ID | D-2003-Pharm |
Entity ID | SAMP |
Scheme | http://www.SampleCompany.com |
Period | from 2003-01-01 to 2003-12-31 |
Scenario | company:By Region (Placeholder)//company:All Regions |
Scenario | company:By Product (Placeholder)//company:Pharmaceuticals Segment |
|
ID | D-2002-Pharm |
Entity ID | SAMP |
Scheme | http://www.SampleCompany.com |
Period | from 2002-01-01 to 2002-12-31 |
Scenario | company:By Region (Placeholder)//company:All Regions |
Scenario | company:By Product (Placeholder)//company:Pharmaceuticals Segment |
|
ID | D-2001-Pharm |
Entity ID | SAMP |
Scheme | http://www.SampleCompany.com |
Period | from 2001-01-01 to 2001-12-31 |
Scenario | company:By Region (Placeholder)//company:All Regions |
Scenario | company:By Product (Placeholder)//company:Pharmaceuticals Segment |
|
ID | D-2003-Gen |
Entity ID | SAMP |
Scheme | http://www.SampleCompany.com |
Period | from 2003-01-01 to 2003-12-31 |
Scenario | company:By Region (Placeholder)//company:All Regions |
Scenario | company:By Product (Placeholder)//company:Generics Segment |
|
ID | D-2002-Gen |
Entity ID | SAMP |
Scheme | http://www.SampleCompany.com |
Period | from 2002-01-01 to 2002-12-31 |
Scenario | company:By Region (Placeholder)//company:All Regions |
Scenario | company:By Product (Placeholder)//company:Generics Segment |
|
ID | D-2001-Gen |
Entity ID | SAMP |
Scheme | http://www.SampleCompany.com |
Period | from 2001-01-01 to 2001-12-31 |
Scenario | company:By Region (Placeholder)//company:All Regions |
Scenario | company:By Product (Placeholder)//company:Generics Segment |
|
ID | D-2003-ConHealth |
Entity ID | SAMP |
Scheme | http://www.SampleCompany.com |
Period | from 2003-01-01 to 2003-12-31 |
Scenario | company:By Region (Placeholder)//company:All Regions |
Scenario | company:By Product (Placeholder)//company:Consumer Health Segment |
|
ID | D-2002-ConHealth |
Entity ID | SAMP |
Scheme | http://www.SampleCompany.com |
Period | from 2002-01-01 to 2002-12-31 |
Scenario | company:By Region (Placeholder)//company:All Regions |
Scenario | company:By Product (Placeholder)//company:Consumer Health Segment |
|
ID | D-2001-ConHealth |
Entity ID | SAMP |
Scheme | http://www.SampleCompany.com |
Period | from 2001-01-01 to 2001-12-31 |
Scenario | company:By Region (Placeholder)//company:All Regions |
Scenario | company:By Product (Placeholder)//company:Consumer Health Segment |
|
ID | D-2003-OtherSeg |
Entity ID | SAMP |
Scheme | http://www.SampleCompany.com |
Period | from 2003-01-01 to 2003-12-31 |
Scenario | company:By Region (Placeholder)//company:All Regions |
Scenario | company:By Product (Placeholder)//company:Other Segments |
|
ID | D-2002-OtherSeg |
Entity ID | SAMP |
Scheme | http://www.SampleCompany.com |
Period | from 2002-01-01 to 2002-12-31 |
Scenario | company:By Region (Placeholder)//company:All Regions |
Scenario | company:By Product (Placeholder)//company:Other Segments |
|
ID | D-2001-OtherSeg |
Entity ID | SAMP |
Scheme | http://www.SampleCompany.com |
Period | from 2001-01-01 to 2001-12-31 |
Scenario | company:By Region (Placeholder)//company:All Regions |
Scenario | company:By Product (Placeholder)//company:Other Segments |
|
ID | D-2003-US |
Entity ID | SAMP |
Scheme | http://www.SampleCompany.com |
Period | from 2003-01-01 to 2003-12-31 |
Scenario | company:By Region (Placeholder)//company:US and Canada Region |
Scenario | company:By Product (Placeholder)//company:All Products |
|
ID | D-2002-US |
Entity ID | SAMP |
Scheme | http://www.SampleCompany.com |
Period | from 2002-01-01 to 2002-12-31 |
Scenario | company:By Region (Placeholder)//company:US and Canada Region |
Scenario | company:By Product (Placeholder)//company:All Products |
|
ID | D-2001-US |
Entity ID | SAMP |
Scheme | http://www.SampleCompany.com |
Period | from 2001-01-01 to 2001-12-31 |
Scenario | company:By Region (Placeholder)//company:US and Canada Region |
Scenario | company:By Product (Placeholder)//company:All Products |
|
ID | D-2003-Europe |
Entity ID | SAMP |
Scheme | http://www.SampleCompany.com |
Period | from 2003-01-01 to 2003-12-31 |
Scenario | company:By Region (Placeholder)//company:Europe Region |
Scenario | company:By Product (Placeholder)//company:All Products |
|
ID | D-2002-Europe |
Entity ID | SAMP |
Scheme | http://www.SampleCompany.com |
Period | from 2002-01-01 to 2002-12-31 |
Scenario | company:By Region (Placeholder)//company:Europe Region |
Scenario | company:By Product (Placeholder)//company:All Products |
|
ID | D-2001-Europe |
Entity ID | SAMP |
Scheme | http://www.SampleCompany.com |
Period | from 2001-01-01 to 2001-12-31 |
Scenario | company:By Region (Placeholder)//company:Europe Region |
Scenario | company:By Product (Placeholder)//company:All Products |
|
ID | D-2003-Asia |
Entity ID | SAMP |
Scheme | http://www.SampleCompany.com |
Period | from 2003-01-01 to 2003-12-31 |
Scenario | company:By Region (Placeholder)//company:Asia Region |
Scenario | company:By Product (Placeholder)//company:All Products |
|
ID | D-2002-Asia |
Entity ID | SAMP |
Scheme | http://www.SampleCompany.com |
Period | from 2002-01-01 to 2002-12-31 |
Scenario | company:By Region (Placeholder)//company:Asia Region |
Scenario | company:By Product (Placeholder)//company:All Products |
|
ID | D-2001-Asia |
Entity ID | SAMP |
Scheme | http://www.SampleCompany.com |
Period | from 2001-01-01 to 2001-12-31 |
Scenario | company:By Region (Placeholder)//company:Asia Region |
Scenario | company:By Product (Placeholder)//company:All Products |
|
ID | D-2003-OtherRegions |
Entity ID | SAMP |
Scheme | http://www.SampleCompany.com |
Period | from 2003-01-01 to 2003-12-31 |
Scenario | company:By Region (Placeholder)//company:Other Regions |
Scenario | company:By Product (Placeholder)//company:All Products |
|
ID | D-2002-OtherRegions |
Entity ID | SAMP |
Scheme | http://www.SampleCompany.com |
Period | from 2002-01-01 to 2002-12-31 |
Scenario | company:By Region (Placeholder)//company:Other Regions |
Scenario | company:By Product (Placeholder)//company:All Products |
|
ID | D-2001-OtherRegions |
Entity ID | SAMP |
Scheme | http://www.SampleCompany.com |
Period | from 2001-01-01 to 2001-12-31 |
Scenario | company:By Region (Placeholder)//company:Other Regions |
Scenario | company:By Product (Placeholder)//company:All Products |